← Back
$CRSP All transactions

CRISPR Therapeutics AG

A

$ Value

$0

Shares

25,000

Price

$0

Filed

Jun 3

Insider

Name

Patel Naimish

Title

Chief Medical Officer

CIK

0002021679

Roles

Officer

Transaction Details

Transaction Date

2025-05-30

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

25,000

Footnotes

Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. | This restricted stock unit award was granted on May 30, 2025 with respect to 25,000 Common Shares, with 100% of the shares vesting on May 30, 2028.

Filing Info

Accession No.

0000950170-25-081361

Form Type

4

Issuer CIK

0001674416

Patel Naimish's History

Date Ticker Type Value
2026-03-20 CRSP A $0
2026-03-20 CRSP A $0
2025-10-03 CRSP A $0
2025-05-30 CRSP A $0
2025-05-29 CRSP $141K
2025-05-28 CRSP M
2025-05-28 CRSP M

Other Insiders at CRSP (90d)

Insider Bought Sold Last
Kulkarni Samarth
Chief Executive Officer
$469K 2026-03-23
KASINGER JAMES R.
General Counsel and Secretary
$149K 2026-03-23
Prasad Raju
Chief Financial Officer
$173K 2026-03-23
Patel Naimish
Chief Medical Officer
2026-03-20